Quantcast

Posts related to ‘SNY’

Berkshire Hathaway & Buffett’s Latest Stock Holdings ‘S to Z’ (BRK-B, BRK-A, SNY, TMK, USB, USG, UPS, WMT, WPO, WFC, WSC)

Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) is out with the new portfolio holdings as of December 31, 2010, so these are his new 2011 investments.  There were many changes in ...
Read Full Story »

Mergers As Far As The Eyes Can See (AOL, BEC, DHR, BRK-A, BRK-B, WSC, ESV, PDE, SNY, GENZ, GGOX, ENWV)

They call it "Merger Monday" for a reason.  Today's news is not dominated by football hangovers.  It is dominated by a slew of headlines over mergers, mergers, and more mergers.  ...
Read Full Story »

Genzyme Pact Seems to Indicate $80 More Likely in Merger (GENZ, SNY)

Genzyme Corporation (NASDAQ: GENZ) is getting closer to capitulating to the offer to be acquired by Sanofi-Aventis (NYSE: SNY).  At issue this morning is that Genzyme has agreed to open ...
Read Full Story »

Warren Buffett’s Ten Best Investments For 2011 (BRK-A, BRK-B, AXP, BAC, BK, GCI, GE, KFT, MCO, PG, UPS, WFC, WMT, SNY, GSK)

Investors have tried for years to follow the strategy of Warren Buffett, considered by many to be the greatest investor in history. That's ironic given how little he seems to ...
Read Full Story »

Berkshire Hathaway & Buffett’s Latest Stock Holdings ‘S to Z’ (BRK-B, BRK-A, SNY, TMK, USB, USG, UPS, WMT, WPO, WFC, WSC)

Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) has shown its latest holdings as of the close on September 30, 2010. The changes were big on the first two lists but more ...
Read Full Story »

Big Risks in Genzyme As Sanofi-Aventis Bid Goes Hostile (GENZ, SNY)

The Sanofi-Aventis (NYSE: SNY) acquisition attempt of Genzyme Corp. (NASDAQ: GENZ) is taking a turn in a strange direction.  The company is holding out for more than the $69.00 cash ...
Read Full Story »

Genzyme Set For Higher Bid? (GENZ, SNY)

The proposed merger and acquisition of Genzyme Corporation (NASDAQ: GENZ) by Sanofi-Aventis (NYSE: SNY) is about to get interesting.  There is a building collective thought that a higher bid price ...
Read Full Story »

Biofuel Maker Sets IPO Price (CDXS, PALG, SNY)

A lot of companies are working on developing microbes to eat something ordinary and expel something extraordinary, like diesel fuel or methane or butanol. Laboratory scale projects have all proved ...
Read Full Story »

BioHealth Business Daily, Major News Breaks (QCOR, DNDN, GERN, STEM, ASTM, CYTX, NBS, BTIM, PSTI, SVA, VVUS, OREX, ARNA, SNTS, GENZ, SNY, TEVA, AMGN, ACOR, CELG, HGSI, BIIB, GILD, EXAS, ZGEN, DYAX, IDXX, VPHM)

Biotech and BioHealth stocks are on the move today and there is more news in the emerging sector than there has been on a single day in months and months.  ...
Read Full Story »

The Unusual Suspects for the Week Ahead (BKS, BRCD, CSKI, CIEN, FNFG, NAL, GENZ, SNY, LULU, ID, NFLX, NE, PBR, RTN, SKS, TTWO, THQI, CALL)

The cast of characters in this week's Unusual Suspects is not any ordinary group of companies.  There are many key stocks to watch for investors that have carryover issues from ...
Read Full Story »

Media Digest (8/30/2010) Reuters, WSJ, NYTimes, FT, Bloomberg

Reuters:   The Bank of Japan eased policy to fight a rise in the yen. Reuters:   Obama said the economy is not growing fast enough. Reuters:   Intel (NASDAQ: INTC) will buy ...
Read Full Story »

Berkshire Hathaway & Buffett’s Latest Stock Holdings ‘S to Z’ (BRK-B, BRK-A, SNY, TIF, TMK, USB, USG, UPS, WMT, WPO, WFC, WSC)

Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) has shown its latest holdings as of the close on June 30, 2010. These have been broken down into 3 groups of ‘A to ...
Read Full Story »

Genzyme Needs to Update Its Merger Status (GENZ, SNY, PFE, AMGN, JNJ)

Genzyme Corporation (NASDAQ: GENZ) still has an incredible merger 'deal premium' associated with it over a pending Sanofi-Aventis (NYSE: SNY) buyout.  Genzyme's troubles have left it vulnerable to a deal ...
Read Full Story »

Top Analyst Upgrades & Downgrades (AGU, ACAS, CIB, ERTS, KGC, MWA, PCLN, SNY, SIRI)

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Thursday morning: Agrium (NYSE: AGU) has seen targets raised at CIBC, Canaccord, ...
Read Full Story »

Genzyme: When Buyout Premiums Become Opaque (GENZ, SNY, JNJ, GSK, BIIB)

All of the freshest reports have the Genzyme Corporation (NASDAQ: GENZ) buyout discussions between Sanofi-Aventis (NYSE: SNY) as being a friendly merger.  The first discussions noted by the WSJ were ...
Read Full Story »